• Tidak ada hasil yang ditemukan

Hubungan Derajat Skor CURB-65 Saat Awal Masuk Pada Pasien Pneumonia Komunitas Terhadap Nilai Antithrombin III (AT-III)

N/A
N/A
Protected

Academic year: 2017

Membagikan "Hubungan Derajat Skor CURB-65 Saat Awal Masuk Pada Pasien Pneumonia Komunitas Terhadap Nilai Antithrombin III (AT-III)"

Copied!
5
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

Abidin A. Management of Community Acquired Pneumonia. Dalam : Naskah lengkap

11th

Abraham E. (2000) Coagulation Abnormalities in Acute Lung Injury and Sepsis. Am. J.

Respir. Cell Mol. Biol. 22:401–4.

Annual Scientific meeting Internal Medicine 2010. Semarang. Badan penerbit USU

press.2010; p. 132-42.

Agapakis DI, Tsantilas D, Psarris P, Massa EV, KotsaftisP, Konstantinos Tziomalos K,

Hatzitolios AI. Coagulation and Inflammation Biomarkers May Help Predict The

Severity of Community-Acquired Pneumonia. Respirology.2010; 15: 796-803.

American College of Chest Physicians/Society of Critical Care Medicine Consensus

Conference: Definitions for Sepsis and Organ Failure and Guidelines for The Use of

InnovativeTherapies in Sepsis. Critical Care Medicine, 1992. Vol 20 no 6.and Prevention

National Center for Health Statistics National Vital Statistics System. Deaths: final data.

National Vital Statistics Reports, 2011.Vol. 61, No. 6.

Arash A, et al.Antithrombin III in critically ill patients: Systematic Review with

Meta-Analysis and Trial Sequential Meta-Analysis.BMJ.2007 : 1-9.

Capelastegui A, Espana PP, Quintana JM, Arcitio I, Gorondo I, Egurolla M, et.al.

Validation of Predictive Rule for the Management of Community Acquired Pneumoniae.

Eur Respir J. 2006; 27: 151-57.

Choi G, Scultz MJ, van Till JWO et al. Disturbed Alveolar Fibrin Turnover During

(2)

Christ-Crain M, Opal SM. Clinical Review: The Role of Biomarkers in the Diagnosis and

Management of Community Acquired Pneumonia. Critical care.2010; 14: 1- 11.

Dahlan Z, Pneumonia. Dalam: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata M, Setiati

S (editors).Buku Ajar Ilmu Penyakit Dalam.Jakarta 2009;2196-2205.

De Frances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge

Survey. National Health Statistic Reports. 2008;5: 1-20.

Donna L. Hoyert, Ph.D. and Jiaquan Xu, M.D.; Centers for Disease Control and

Prevention National Center for Health Statistics National Vital Statistics System.

Deaths: final data. National Vital Statistics Reports, 2011.Vol. 61, No. 6.

Escobar CE, et al., Introduction to hemostasis. In: Harmening DM, ed. Clinical

Hematology and Fundamentals of Hemostasis. 4th ed. Philadelphia, PA: FA Davis

Company; 2002:441-470.

Fourreir F, et al Septic Shock, Multiple Organ Failure and Disseminated Intravascular

Coagulation Compared Pattern of Antithrombin III, Protein C and Protein S Deficiencies.

Hardiyanto UM.Tinjauan beberapa aspek penderita Pneumonia yang dirawat di

SMF/Bagian IP Dalam RSUP Hasan Sadikin, Bandung tahun 1995-1996. FK Unpad

1998.

Huang HH, Zhang YY, Xiu QY, et al. Community-Acquired Pneumonia in

Shanghai,China: Microbial Etiology and Implications for Empirical Therapy in a

Prospective Study of 389 patients. Eur J Clin Microbiol Infect Dis 2006;25:369–74.

Idell S. Coagulation, Fibrinolysis and Fibrin Deposition in Acute Lung Injury. Crit. Care

Med. 2003; 31: S213–20.

Jerry B.L,Coagulation Pathway and Physiology.An Algorithmic Approach to Hemostasis

Testing, 2008 – PK staging.PK.org.

30

(3)

Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, et.al.

Pneumonia: Still the Oldman’s Friend. Arch Intern Med. 2003; 163: 317-23

Kasper, Braunwald, Fauci, Hauser, Longo, Jameson(Editors). Sepsis and Septic Shock.

Harrison’s Manual Of Medicine, 18 th Edition, Mc Graw Hill, 2005:49-53

Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, et.al. Severe

Community Acquired Pneumoniae As Cause Of Severe Sepsis: Data from PROWESS

study. Crit Care Med, 2005; 33(5): 952-61.

Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar Coagulation and

Fibrinolysis in Endotoxemia and Pneumonia. Crit Care Med.2003;31:238-42.

Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Jeune IL, et.al. British

Thoracic Society Guidelines For The Management of Community Acquired Pneumoniain

Adults: update 2009. Thorax. 2009; 64(suppl II) : 1- 55.

Mandell LA, Wunderik RG, Arzueto A, Bartlett JG, Campbell GD, Dean NC, et.al.

Infectious Diseases Society of America/ American Thoracic Society Consensus

Guidelines on The Management of Community Acquired Pneumonia in Adults. CID.

2007; 44: 27- 72.

Marianne N, Richard J. B, Coagulation Dysfunction in Sepsis and Multiple Organ

System Failure. Crit Care Clin 19 (2003) 441 – 458.

Milbrandt EB, Reade MC, Lee MJ, Shook SL, Angus DC, Kong L, et al. Prevalence and

Significance of Coagulation Abnormalities in Community-acquired Pneumonia.

Molecular medicine. 2009; 15(11-12): 438–445.

Mira JP, Max A, Burgel PR. The Role of Biomarker in Community Acquired Pneumonia:

Prediciting Mortality and Response to Adjunctive Therapy. Critical Care. 2008;12(Suppl

(4)

Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et.al. Diagnostic and

Prognostic Accuracy of Clinical and Laboratory Parameters in Community Acquired

Pneumonia. BMC Infectious Diseases.2007; 7: 1- 10.

Perhimpunan Dokter Paru Indonesia.Pneumonia Komunitas, pedoman diagnosis &

penatalaksanaan di Indonesia. Jakarta: PDPI, 2003. h.1-38

Pettilä V,Pentti J,Pettilä M,Takkunen O, Jousela I,et al.Predictive Value of Antithrombin

III and Serum C-reactive Protein Concentration in cCitically Ill Patients with Suspected

Sepsis.Crit Care Med 2002; 30:271–275.

Proietta M, Pulignano I, Porto F et al. Antithrombin III Metabolism In The pulmonary

Vessel Endothelium. Blood Coagul. Fibrinolysis 2007; 18: 237–40.

Ribelles JMQ, Tenias JM, Grav E, Querol-Borras JM, Climent JL, Gomez E, et.al.

Plasma d-dimer levels Correlate with Outcomes in Patient with Community Acquired

Pneumonia. Chest.2004; 126: 1087-92.

Rijneveld AW, et al. (2006) Local Activation of The Tissue Factor-factor VIIa Pathway

in Patients with Pneumonia and The Effect of Inhibition of This Pathway in Murine

Pneumococcal Pneumonia. Crit. Care Med. 34:1725–730.

S. Ewig et al.Severity Assessment in Community-Acquired PneumoniaeEur Respir J

2000; 16: 1193-1201.

Saito A, Kohno S, Matsushima T, et al. Prospective Multicenter Study of The Causative

Organisms of Community-Acquired Pneumonia in Adults in Japan. J Infect Chemother

2006;12:63–9.

Singanayagam A, Chalmers JD, Hill AT. Severity Assesment in Community Acquired

Pneumonia: a review. QJ med. 2009; 102: 379-88.

Suharti. Dasar-dasar HemostasisDalam: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata

M, Setiati S (editors).Buku Ajar Ilmu Penyakit Dalam.Jakarta 2009;1293-1300.

Summary Executive. Pola Penyakit Penyebab Kematian di Indonesia. Survei Kesehatan

Rumah Tangga (SKRT). 2001: 2.

32

(5)

Thomas M F, Jr, MD, Prognosis of Community-Acquired Pneumonia in adults. 2011,

available in: http://www.uptodate.com.

Torres A. Update in Community-acquired and Nosocomial Pneumoniae. Pulmonary and

Critical Care Updates.Am J Respir Crit Care Med Vol 181. pp 782–787, 2010.

Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-Acquired Pneumonia

in southeast Asia: The Microbial Differences Between Ambulatory and Hospitalized

Patients. Chest 2003;123:1512–9.

Referensi

Dokumen terkait

Kepada Bapak/Ibu yang bersedia mengikuti penelitian ini nantinya akan diminta mengisi surat persetujuan ikut dalam penelitian, mengikuti wawancara untuk mencari adanya hal-hal

Procalcitonin merupakan biomarker infeksi bakteri yang memiliki hubungan dengan derajat keparahan PK yang dinilai dengan skor CURB-65 sehingga PCT dapat

serta seluruh keluarga besar penulis yang telah banyak memberikan bantuan moril, semangat dan doa tanpa pamrih selama pendidikan, sehingga penulis dapat sampai di titik ini, yang

D-dimer levels in assessing severity and clinical outcome in patients withcommunity-acquired pneumonia.. European Journal of Internal Medicine,

D dimer merupakan biomarker koagulasi yang memiliki hubungan dengan derajat keparahan PK yang dinilai dengan skor CURB-65 sehingga D dimer dapat digunakan untuk menentukan

perhatiannya senantiasa membimbing penulis selama mengikuti pendidikan. Penulis haturkan rasa hormat dan terima kasih yang tak terhingga. Direktur dan mantan Direktur Rumah Sakit

Simpulan, AT-III merupakan biomarker koagulasi yang memiliki hubungan dengan derajat keparahan PK yang dinilai dengan skor CURB-65 sehingga AT-III dapat digunakan untuk

Simpulan, AT-III merupakan biomarker koagulasi yang memiliki hubungan dengan derajat keparahan PK yang dinilai dengan skor CURB-65 sehingga AT-III dapat digunakan untuk